A Case of Stiff Person Syndrome
Open Access
- 1 June 2015
- journal article
- case report
- Published by Wolters Kluwer Health in Medicine
- Vol. 94 (23) , e954
Abstract
Stiff person syndrome (SPS) is a rare autoimmune disease. Most patients have high-titer antibodies against glutamate decarboxylase (GADAb), which is without practical value in disease monitoring. Benzodiazepines are the first line drugs, but long-term use is not well characterized. This report demonstrates ineffective benzodiazepine therapy of SPS that prompts tachyphylaxis, loss of responsiveness, and finally benzodiazepine withdrawal syndrome. Convulsion and anxiety correlate with high level of creatine phosphokinase (CK). Although tonus and spasm attacks were successfully controlled by tizanidine, glutamate release inhibitor, the immune response, and autoimmune diabetes development require the plasmapheresis, mycophenolat mofetil, and rituximab therapy that results in a significant decrease of GADAb, impaired glucose tolerance (IGT), lactate dehydrogenase (LDH), and CK normalization. Unfortunately, reintroduction of benzodiazepine was a source of rapid and high increase of CK, LDH, GADAb titer (up to 1:15,000), IGT, and SPS relapse. Contrary to previous publications, we observed IGT that correlated with high anti-GAD level, but without high immunogenetic susceptibility to haplotype human leukocyte antigens-DR3, DQw2. This preliminary observation and the last finding of immunomodulatory properties of peripheral benzodiazepine receptor suggest that increased antigenic stimulation during benzodiazepine therapy and glutamatergic hyperactivity could account for convulsions observed in SPS. Benzodiazepine withdrawal prompted alternative muscle relaxant therapy (tizanidine). Muscular and brain abnormalities observed in SPS indicate that noncardiac CK level may be a useful tool in SPS therapy monitoring.Keywords
This publication has 16 references indexed in Scilit:
- Peripheral benzodiazepine receptor regulates vascular endothelial activations via suppression of the voltage‐dependent anion channel‐1FEBS Letters, 2012
- HLA-DQB1 genotypes and islet cell autoantibodies against GAD65 and IA-2 in relation to development of diabetes post partum in women with gestational diabetes mellitusDiabetes Research and Clinical Practice, 2012
- Actions of translocator protein ligands on neutrophil adhesion and motility induced by G-protein coupled receptor signalingBiochemical and Biophysical Research Communications, 2012
- Stiff person syndromePractical Neurology, 2011
- Human Stiff-Person Syndrome IgG Induces Anxious Behavior in RatsPLOS ONE, 2011
- GAD Autoantibody Affinity and Epitope Specificity Identify Distinct Immunization Profiles in Children at Risk for Type 1 DiabetesDiabetes, 2007
- The lack of expression of the peripheral benzodiazepine receptor characterises microglial response in anaplastic astrocytomasJournal of Neuro-Oncology, 2007
- Impaired Fasting Glucose and Impaired Glucose ToleranceDiabetes Care, 2007
- Stiff-person Syndrome Associated with Cerebellar Ataxia and High Glutamic Acid Decarboxylase Antibody Titer.Internal Medicine, 2001
- Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus.Journal of Experimental Medicine, 1994